MetLife Investment Management, LLC - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 298 filers reported holding NEOGENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$828,307
-23.5%
67,3420.0%0.01%
-12.5%
Q2 2023$1,082,186
-6.4%
67,342
+1.4%
0.01%
-11.1%
Q1 2023$1,156,651
+88.4%
66,4360.0%0.01%
+80.0%
Q4 2022$613,869
+9.2%
66,436
+1.7%
0.01%0.0%
Q3 2022$562,336
+12.2%
65,312
+6.2%
0.01%
+25.0%
Q2 2022$501,298
-32.9%
61,5090.0%0.00%
-20.0%
Q1 2022$747,334
-44.0%
61,509
+57.4%
0.01%
-54.5%
Q4 2021$1,333,580
-29.3%
39,0850.0%0.01%
-35.3%
Q3 2021$1,885,460
+2.3%
39,085
-4.2%
0.02%
-5.6%
Q2 2021$1,843,749
-6.3%
40,8180.0%0.02%
-5.3%
Q1 2021$1,968,652
-14.4%
40,818
-4.4%
0.02%
-17.4%
Q4 2020$2,299,776
+36.2%
42,715
-6.7%
0.02%
+21.1%
Q3 2020$1,688,640
+19.1%
45,7750.0%0.02%
+18.8%
Q2 2020$1,418,110
+28.8%
45,775
+14.8%
0.02%0.0%
Q1 2020$1,100,617
-10.8%
39,863
-5.5%
0.02%
+23.1%
Q4 2019$1,233,268
+53.0%
42,1630.0%0.01%
+44.4%
Q3 2019$806,157
-7.4%
42,163
+6.2%
0.01%
-10.0%
Q2 2019$870,775
+16.2%
39,689
+8.3%
0.01%
+25.0%
Q1 2019$749,613
+124.3%
36,638
+38.3%
0.01%
+100.0%
Q4 2018$334,127
-17.9%
26,4970.0%0.00%0.0%
Q3 2018$406,729
+17.2%
26,4970.0%0.00%0.0%
Q2 2018$347,000
+60.6%
26,4970.0%0.00%
+33.3%
Q1 2018$216,000
-8.1%
26,4970.0%0.00%0.0%
Q4 2017$235,00026,4970.00%
Other shareholders
NEOGENOMICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Kopp Family Office, LLC 2,023,355$91,395,00037.83%
Blue Water Life Science Advisors, LP 702,222$31,719,00011.94%
Burrage Capital Management LLC 147,921$6,682,0006.70%
PERKINS CAPITAL MANAGEMENT INC 158,300$7,150,0004.06%
First Light Asset Management, LLC 1,148,945$51,898,0003.11%
Soleus Capital Management, L.P. 352,007$15,900,0002.44%
Ranger Investment Management 832,286$37,594,0001.96%
Avidity Partners Management LP 1,367,000$61,747,0001.67%
Bullseye Asset Management LLC 108,672$4,909,0001.65%
Tygh Capital Management, Inc. 255,541$11,543,0001.57%
View complete list of NEOGENOMICS INC shareholders